Studies Towards the Formal and Total Syntheses of Ginkgolide Natural Products

该项目属于EPSRC合成有机化学研究领域。全合成是整个化学的核心。通过寻找制造复杂分子的新方法，化学家可以解决在方法学、光谱学、结构分析和计算化学等领域具有深远影响的问题。特别是，天然分子的完全合成——天然产物——允许发现新的药物分子和发展医学治疗。例如，Newman和Cragg在最近的一篇综述中强调，自从1946年第一种抗肿瘤药物获得批准以来，大多数临床批准的小分子抗癌药物都来自天然产物。在此背景下，目前的项目将重点研究银杏内酯家族天然产物的合成。在中国发现的银杏提取物在治疗中枢神经系统疾病——多发性硬化症、帕金森症、阿尔茨海默症——以及不太严重的认知疾病方面显示出了希望；例如，耳鸣和偏头痛。人们认为，最初于1932年分离的银杏内酯是这些提取物治疗潜力的关键。因此，它们是一类相关的分子，值得研究。本项目的目的是完成一种新的形式合成银杏内酯B，并研究剩余的银杏内酯天然产物的不对称合成的潜力。将重点放在步骤的经济性上，改进先前报道的合成方法。银杏内酯的结构非常复杂，对其合成提出了重大挑战。这种复杂性的主要来源是大量连续的立体中心和叔丁基的存在-这在天然产物中是罕见的。因此，该项目提供了开发新策略和方法的可能性，并以新的方式利用以前开发的反应。最后，银杏内酯的成功合成将使其衍生物作为潜在药物的研究成为可能。

This project falls within the EPSRC Synthetic Organic Chemistry research area. Total synthesis is central to chemistry as a whole. By finding new ways to make complex molecules, chemists tackle problems which can have far reaching consequences in fields such as methodology, spectroscopy, structural analysis, and computational chemistry, among others. In particular, the total synthesis of naturally occurring molecules - natural products - allows for the discovery of new drug molecules and the development of medical treatments. For example, Newman and Cragg highlighted in a recent review that since the approval of the first anti-tumour agent in 1946 the majority of clinically approved small molecule anti-cancer agents has been derived from natural products. In this context, the current project will focus on the synthesis of the ginkgolide family of natural products. Extracts from the Ginkgo biloba tree, found in China, have shown promise in the treatment of central nervous system disorders - multiple sclerosis, Parkinson's, Alzheimer's - as well as less severe cognitive ailments; e.g., tinnitus and migraines. It is believed that the ginkgolides, originally isolated in 1932, are key to the therapeutic potential of these extracts. As such, they are a relevant class of molecules and bear investigating. The aim of this project is to complete a novel formal synthesis of ginkgolide B and to investigate the potential for asymmetric syntheses of the remaining ginkgolide natural products. There will be a focus on economy of steps, improving on previously reported syntheses. Structurally, the ginkgolides are highly complex and pose a significant synthetic challenge. The main sources of this complexity are the numerous contiguous stereocentres and the presence of a tertiary-butyl group - a rarity in natural products. Therefore, this project offers the possibility of developing new strategies and methodologies as well as leveraging previously developed reactions in new ways. Finally, the successful synthesis of the ginkgolides will allow the investigation of derivatives as potential pharmaceuticals.